Emiliania Huxleyi Algae – Powerful Carbon Dioxide Regulators

This year’s first prize of the ZEISS Microscopy Image Contest was awarded to Alicia Gónzales Segura (middle), Dolores Molina Fernández (left) and Isabel Sánchez Almazo (right) from the Centro de Instrumentación Científica at the University of Granada (Spain) for their visually stunning image of Emiliania huxleyi coccospheres. This alga is considered a ubiquitous species found... Read more

Bruker Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can... Read more

PerkinElmer Participates in NIST Program to Advance Cannabis and Hemp Testing Standardization

Company’s Work with Federal organization focused on heavy metals and cannabinoid analysis aimed at helping labs and producers meet key regulations more effectively and efficiently October 19, 2021 WHAT : PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its participation in the National Institute of Standards and Technology’s (NIST)... Read more

PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis

Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 18, 2021– PerkinElmer, Inc. (NYSE: PKI) and Honeycomb Biotechnologies, Inc., announced today the commercial launch of the first of its kind HIVETM scRNAseq Solution for single-cell isolation and analysis. The HIVE solution leverages a... Read more

FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System

FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System CARLSBAD, Calif., Oct. 18, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to run COVID-19 tests from saliva samples collected with the... Read more

Invitation for RSNA2021(Radiological Society of North America) exhibition

Dear all our valued customers, Shimadzu Medical Systems is ready to introduce our latest products and innovative technology at the technical exhibition of RSNA2021 107th Scientific Assembly and Annual Meeting from November 28th to December 1st. In our booth there, you can find many of our advanced imaging solutions & unique applications that will provide... Read more

US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting Approval is based on the Phase III IMpower010 study showing adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive Stage II-IIIA lung cancer, compared with best supportive care Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more

Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care

Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment. Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to improving patient outcomes... Read more

Xylem to Release Third Quarter 2021 Financial Results on November 2, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 14, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its third quarter 2021 results at 6:55 a.m. (ET) on Tuesday, November 2, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more